Is It Almost Over?
With the first COVID vaccine having been approved this week, and with a few more on the way, the end of the COVID pandemic is within view. However, there are still several areas of concern surrounding the vaccine. Many of the more high-profile concerns are already being discussed throughout the medical community and the media. The availability of the vaccines to enough Americans to achieve herd immunity likely will not be here until the summer, at the earliest. The United States opted not to order more than 100 million doses from Pfizer - which won the race for FDA approval - even when offered the opportunity to do so as recently as November. Additionally, the willingness of the general public to take the vaccine is hovering at only about 50% nationally, and we could honestly spend the entirety of this column analyzing whose fault that is.